Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under OnKure Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Liam Ratcliffe, Director (Form 8-K filed 2026-03-30). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Coastlands Capital LP (filed 2026-10-07).
Who is behind it
OnKure Therapeutics, Inc.: incorporated in Delaware; business address in Boulder, Colorado; industry Pharmaceutical Preparations (Schedule 13G, 2026-10-07).
Officers and directors, each with the role and the filing that names them:
- Nicholas Saccomano: Executive Officer, Director (Form D, 2024-10-21)
- Jason Leverone: Executive Officer (Form D, 2024-10-21)
- Samuel Agresta: Executive Officer (Form D, 2024-10-21)
- Dylan Hartley: Executive Officer (Form D, 2024-10-21)
- R. Michael Carruthers: Director (Form D, 2024-10-21)
- Valerie M. Jansen: Director (Form D, 2024-10-21)
- Isaac Manke: Director (Form D, 2024-10-21)
- Andrew Johm Phillips: Director (Form D, 2024-10-21)
- Michael G. Grey: Director (Form D, 2024-10-21)
- Edward T. Mathers: Director (Form D, 2024-10-21)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-07 | Coastlands Capital LP | 6.67% |
| Schedule 13G/A, 2026-08-14 | Adar1 Capital Management, LLC | 5.5% |
| Schedule 13G/A, 2026-08-14 | Trails Edge Capital Partners, LP | 3.6% |
| Schedule 13G/A, 2026-08-14 | Bvf Partners L P/Il | 8% |
| Schedule 13G/A, 2026-08-10 | Prosight Management, LP | 2.4% |
| Schedule 13G, 2026-05-27 | Bvf Partners L P/Il | 5.3% |
| Schedule 13G/A, 2026-05-15 | Adar1 Capital Management, LLC | 6% |
| Schedule 13D, 2026-04-07 | Ai Biotechnology LLC | 19.99% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-03-30 | Liam Ratcliffe | Director | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-10-21 | $65M | $65M |
Latest IPO step: OnKure Therapeutics, Inc. filed to go public (S-1, 2024-10-23).
IPO filings: S-1, 2024-10-23; ticker OKUR on Nasdaq Global Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/onkure-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13G, 2026-10-07 · Form D, 2024-10-21 · Form 8-K, 2026-03-30 · S-1, 2024-10-23
Who owns OnKure Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/onkure-therapeutics